Placebo effects on nausea and motion sickness are resistant to experimentally-induced stress.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
19 06 2023
Historique:
received: 31 10 2022
accepted: 31 05 2023
medline: 21 6 2023
pubmed: 20 6 2023
entrez: 19 6 2023
Statut: epublish

Résumé

Nausea often occurs in stressful situations, such as chemotherapy or surgery. Clinically relevant placebo effects in nausea have been demonstrated, but it remains unclear whether stress has an impact on these effects. The aim of this experimental study was to investigate the interplay between acute stress and placebo effects in nausea. 80 healthy female volunteers susceptible to motion sickness were randomly assigned to either the Maastricht Acute Stress Test or a non-stress control condition, and to either placebo treatment or no treatment. Nausea was induced by a virtual vection drum and behavioral, psychophysiological as well as humoral parameters were repeatedly assessed. Manipulation checks confirmed increased cortisol levels and negative emotions in the stressed groups. In the non-stressed groups, the placebo intervention improved nausea, symptoms of motion sickness, and gastric myoelectrical activity (normo-to-tachy (NTT) ratio). In the stressed groups, the beneficial effects of the placebo intervention on nausea and motion sickness remained unchanged, whereas no improvement of the gastric NTT ratio was observed. Results suggest that placebo effects on symptoms of nausea and motion sickness are resistant to experimentally-induced stress. Stress most likely interfered with the validity of the gastric NTT ratio to measure nausea and thus the gastric placebo effect.

Identifiants

pubmed: 37336972
doi: 10.1038/s41598-023-36296-w
pii: 10.1038/s41598-023-36296-w
pmc: PMC10279757
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

9908

Informations de copyright

© 2023. The Author(s).

Références

Aerosp Med. 1968 May;39(5):453-5
pubmed: 5648730
Psychosom Med. 2011 Feb-Mar;73(2):193-9
pubmed: 21217098
PLoS One. 2020 Sep 23;15(9):e0238533
pubmed: 32966280
Neurogastroenterol Motil. 2004 Dec;16(6):737-44
pubmed: 15601423
BMC Med. 2007 Mar 19;5:3
pubmed: 17371590
Cogn Emot. 2012;26(5):786-99
pubmed: 22077643
Gastroenterology. 1987 Jan;92(1):92-7
pubmed: 3781204
Front Neurosci. 2019 Nov 13;13:1212
pubmed: 31798402
Appl Ergon. 2010 Jul;41(4):494-503
pubmed: 20170902
Biosci Trends. 2020 Mar 16;14(1):35-41
pubmed: 32023559
Psychophysiology. 1975 May;12(3):268-82
pubmed: 1153632
Pain. 2012 May;153(5):1114-1121
pubmed: 22464696
Psychosom Med. 1999 Mar-Apr;61(2):154-62
pubmed: 10204967
Pain. 2017 Aug;158(8):1489-1498
pubmed: 28471874
N Engl J Med. 2011 Jul 14;365(2):119-26
pubmed: 21751905
Annu Rev Pharmacol Toxicol. 2019 Jan 6;59:191-211
pubmed: 30216744
J Physiol. 2015 Mar 1;593(5):1183-96
pubmed: 25557265
Psychosom Med. 2013 Jun;75(5):497-504
pubmed: 23697466
Psychophysiology. 2001 Jul;38(4):642-52
pubmed: 11446577
Psychother Psychosom. 2018;87(4):204-210
pubmed: 29895014
J Psychosom Res. 2019 Oct;125:109808
pubmed: 31426018
Psychosom Med. 2008 Sep;70(7):811-8
pubmed: 18725424
J Psychosom Res. 2016 Dec;91:9-11
pubmed: 27894470
Psychosom Med. 1999 May-Jun;61(3):297-303
pubmed: 10367609
Cereb Cortex. 2013 Apr;23(4):806-13
pubmed: 22473843
J Vis Exp. 2014 Dec 14;(94):
pubmed: 25549015
J Psychosom Res. 2002 Feb;52(2):69-77
pubmed: 11832252
Psychosom Med. 2023 May 1;85(4):298-307
pubmed: 37010234
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Nat Rev Drug Discov. 2013 Mar;12(3):191-204
pubmed: 23449306
Psychosom Med. 2016 Apr;78(3):365-72
pubmed: 26588822
Aviat Space Environ Med. 1989 May;60(5):411-4
pubmed: 2730483
Physiol Behav. 2009 Apr 20;97(1):102-6
pubmed: 19419665
Philos Trans R Soc Lond B Biol Sci. 2011 Jun 27;366(1572):1808-17
pubmed: 21576138
Psychosom Med. 2006 May-Jun;68(3):478-86
pubmed: 16738082
Mol Cell Endocrinol. 2013 Nov 5;380(1-2):2-15
pubmed: 23707790
Handb Exp Pharmacol. 2014;225:183-203
pubmed: 25304533
Int Rev Neurobiol. 2018;138:39-59
pubmed: 29681334
Br J Pharmacol. 2009 Jul;157(6):865-80
pubmed: 19371333
Psychoneuroendocrinology. 2012 Dec;37(12):1998-2008
pubmed: 22608857
Anesthesiology. 2007 Dec;107(6):903-8
pubmed: 18043058
Eur J Pharmacol. 2014 Jan 5;722:108-21
pubmed: 24157981
Acta Psychol (Amst). 2015 Mar;156:77-82
pubmed: 25701720
J Neurosci. 2011 Nov 9;31(45):16117-24
pubmed: 22072664
Neurogastroenterol Motil. 2012 May;24(5):438-45, e211-2
pubmed: 22309404
Acta Biol Hung. 2002;53(4):589-99
pubmed: 12501940
Brain Res Bull. 1998 Nov 15;47(5):507-16
pubmed: 10052582
Nat Rev Neurosci. 2015 Jul;16(7):403-18
pubmed: 26087681
Brain Behav. 2022 Aug;12(8):e2685
pubmed: 35810479
Front Pharmacol. 2019 Apr 25;10:410
pubmed: 31133847
Scand J Gastroenterol. 2009;44(5):557-63
pubmed: 19242858

Auteurs

Carmen Jacob (C)

Institute of Medical Psychology, Medical Faculty, LMU Munich, 80336, Munich, Germany.
Wessex Neurological Centre, University Hospital Southampton and Clinical Neurosciences, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, SO16 6YD, UK.

Elisabeth Olliges (E)

Institute of Medical Psychology, Medical Faculty, LMU Munich, 80336, Munich, Germany.
Department of Psychosomatic Medicine and Psychotherapy, Klinik Barmelweid AG, 5017, Barmelweid, Switzerland.
Division of Health Promotion, Coburg University of Applied Sciences and Arts, Friedrich-Streib-Str. 2, 96450, Coburg, Germany.

Anja Haile (A)

Institute of Medical Psychology, Medical Faculty, LMU Munich, 80336, Munich, Germany.

Verena Hoffmann (V)

Institute of Medical Psychology, Medical Faculty, LMU Munich, 80336, Munich, Germany.

Benjamin Jacobi (B)

Institute of Medical Psychology, Medical Faculty, LMU Munich, 80336, Munich, Germany.
Department of Psychiatry, University of Connecticut Health Center, H1010, Farmington, CT, 06030-1410, USA.

Leander Steinkopf (L)

Institute of Medical Psychology, Medical Faculty, LMU Munich, 80336, Munich, Germany.

Marina Lanz (M)

Institute of Medical Psychology, Medical Faculty, LMU Munich, 80336, Munich, Germany.

Marc Wittmann (M)

Institute for Frontier Areas of Psychology and Mental Health, 79098, Freiburg, Germany.

Matthias H Tschöp (MH)

Institute for Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Zentrum München, 85764, Neuherberg, Germany.
Division of Metabolic Diseases, Department of Medicine, Technische Universität München, 81675, Munich, Germany.

Karin Meissner (K)

Institute of Medical Psychology, Medical Faculty, LMU Munich, 80336, Munich, Germany. karin.meissner@hs-coburg.de.
Division of Health Promotion, Coburg University of Applied Sciences and Arts, Friedrich-Streib-Str. 2, 96450, Coburg, Germany. karin.meissner@hs-coburg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH